Clinical features and assessment of severe dementia. A review

European Journal of Neurology

Volumn 9, Issue 2, 2002, Pages 125-136

  Boller, F ^a,e   Verny, M ^b   Hugonot Diener, L ^c   Saxton, J ^d  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c CEPEVI Groupe MAPI   (France)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e CENTRE PAUL BROCA   (France)

Author keywords

Alzheimer's disease; Behavioural assessment; Dementia; Neuropsychological tests; Severe impairment battery

Indexed keywords

AGITATION; ANXIETY; BEHAVIOR DISORDER; CLINICAL FEATURE; COGNITION; DELUSION; DEMENTIA; DEPRESSION; DISEASE SEVERITY; HALLUCINATION; HUMAN; IMAGING; MOTOR DYSFUNCTION; MYOCLONUS; NEUROCHEMISTRY; NEUROPATHOLOGY; PRIORITY JOURNAL; QUALITY OF LIFE; RATING SCALE; REVIEW;

ALZHEIMER DISEASE; HUMANS; NEUROPSYCHOLOGICAL TESTS; SEVERITY OF ILLNESS INDEX;

EID: 0036046441     PISSN: 13515101     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-1331.2002.00356.x     Document Type: Review

References (90)

1. Relationship of aggressive behaviour to other neuropsychiatric symptoms in patients with Alzheimer's disease
2. The test for severe impairment an instrument for the assessment of patients with severe cognitive dysfunction
3. Cornell scale for depression in dementia
4. The neglected half of Alzheimer disease: Cognitive and functional concomitants of severe dementia
5. Selective impairment of verb processing associated with pathological changes in Brodmann areas 44 and 45 in the motor neurone disease - Dementia-aphasia syndrome
6. Relationship between primitive reflexes, extrapyramidal signs, reflective apraxia and severity of cognitive impairment in dementia of the Alzheimer type
7. Delusions and hallucinations in Alzheimer's disease: Prevalence and clinical correlates
8. The hierarchic dementia scale: Usage
9. Delusions and dementia: Clinical and CT correlates
10. The non-Alzheimer degenerative dementias
11. Processing emotional information in Alzheimer's disease. Effects on memory performance and neurophysiological correlates
12. Affective disturbances in Alzheimer disease
13. Clinical subtypes of dementia of the Alzheimer type
14. Cohen-Mansfield agitation inventory (CMAI)
15. Development of dementia rating scale
16. Dementia with senile plaques and neurofibrillary tangles
17. The neuropsychiatric inventory: Assessing psychopathology in dementia patients
18. Epidémiologie des démences
19. Temporal pattern of cognitive decline and incontinence is different in Alzheimer's disease and diffuse Lewy body disease
20. Étalonnage d'une échelle d'évaluation cognitive de structure modulaire et hiérarchisée applicable aux démences. Version française modifiée de la Hierarchic Dementia Scale
21. Control of agression and agitation in patients with dementia: Efficacy and safety of risperidone
22. L'ECD GRECO: Échelle du comportement pour la démence
23. Abnormal behaviour associated with dementia
24. Mood and behaviour
25. Carbamazepine in dementia
26. The neurologic syndrome of severe Alzheimer's disease. Relationship to functional decline
27. Epidemiology of Alzheimer's disease and current possibilities for prevention
28. Epidemiology of dementia
29. A 2-year follow-up of behavioural and psychological symptoms in Alzheimer's disease
30. Survival in institutionalized patients: Influence of dementia and loss of functional capacities
31. The neuropsychology of frontal variant frontotemporal dementia and semantic dementia. Introduction to the special topic papers: Part II
32. A new clinical scale for the staging of dementia
33. Amnestic people with Alzheimer's disease who remembered the Kobe earthquake
34. Pharmacologic treatment of noncognitive symptoms of dementia
35. Index of ADL
36. Natural history of aggressive behaviour in dementia
37. Cognition
38. Assessing patterns of agitation in Alzheimer's disease patients with the Cohen-Mansfield Agitation Inventory. The Alzheimer's disease cooperative study
39. Pharmacologic approach to management of agitation associated with dementia
40. Assessment of older people: Self-maintaining and instrumental activities of daily living
41. Frequency and presentation of depressive symptoms in patients with primary degenerative dementia
42. Evaluation comportementale dans la démence de type Alzheimer par le questionnaire de dyscontrôle comportemental
43. Validaciòn de la adaptaciòn española de la Severe Impairment Battery (SIB)
44. Wandering: A significant problem among community-residing individuals with Alzheimer's disease
45. Noncognitive disturbances in Alzheimer's disease: Frequency, longitudinal course, and relationship to cognitive symptoms
46. Mental status examination for organic mental syndrome in the elderly patients
47. Diagnostic problems in nursing home patients with dementia: Why we should and how we can improve accuracy
48. Heterogeneity in dementia of the Alzheimer type: Evidence of subgroups
49. Cognitive and affective assessment and muliple pathologies in institutionalized elderly
50. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
51. Visual hallucinations in blindness (the Charles Bonnet syndrome)
52. The psychiatric symptoms of Alzheimer's disease
53. Relationship between falls and stride length variability in senile dementia of the Alzheimer type
54. Gait disturbances in Alzheimer's disease: A clinical study
55. Typologie des démences vasculaires et de type Alzheimer: Résultats de l'évaluation gérontologique de 178 patients
56. Batterie d'évaluation neuropsychologique pour la démence grave
57. Slowly progressive aphasia: A four-year follow-up study
58. Aggressive behaviour in elderly people with dementia: A review
59. Neuropsychological assessment of severely demented elderly
60. Factorial validation of the Severe Impairment Battery (SIB) for patients with Alzheimer's disease. A pilot study
61. Neuropsychological assessment of the severely impaired elderly patient: Validation of the Italian short version of the Severe Impairment Battery (SIB)
62. Functionnal Assessment Staging (FAST)
63. The Global Deterioration Scale for assessment of primary degenerative dementia
64. Behavioral symptoms in Alzheimer's disease: Phenomenology and treatment
65. Dementia staging in chronic care populations
66. La démence sénile en France: Une estimation de la charge actuelle et projection des tendances futures
67. L'inventaire neuropsychiatrique: Validation de la version Française d'un instrument destiné à évaluer les troubles du comportement chez le sujet dément
68. Reliability and validity of the Hierarchic Dementia Scale
69. Discrimination of facial identity and of emotions in Alzheimer's disease
70. Depression and Alzheimer's disease
71. Assessment of the severely impaired patient: Description and validation of a new neuropsychological test battery
72. The Severe Impairment Battery: Concurrent validity and the assessment of longitudinal change in Alzheimer's disease
73. The behaviour pathology in Alzheimer's disease rating scale (BEHAVE-AD): Reliability and analysis of symptom category scores
74. Alzheimer's disease: Its natural history and differential diagnosis
75. Severe disruptive vocalizers
76. Contractures and loss of function in patients with Alzheimer's disease
77. Predictors of disease course in patients with probable Alzheimer's disease
78. Behavioral disturbances in dementia of Alzheimer's type
79. Cognitive decline in Alzheimer's disease: A longitudinal investigation of risk factors for accelerated decline
80. Anxiety of Alzheimer's disease: Prevalence, and comorbidity
81. Visual hallucinations in psychologically normal people: Charles Bonnet's syndrome
82. Unilateral spatial neglect in the late stage of Alzheimer's disease
83. Démence à un stade très évolué
84. Evaluation de la démence sévère: Échelles cognitives et comportementales (groupe de travail du GRECO)
85. The challenge of dementia in Canada - From research to practice
86. Overview of depression and psychosis in Alzheimer's disease
87. Management of the behavioural manifestations of dementia